Genetically Controlled Lysosomal Entrapment of Superparamagnetic Ferritin for Multimodal and Multiscale Imaging and Actuation with Low Tissue Attenuation

Abstract

Nanomaterials are of enormous value for biomedical applications because of their customizable features. However, the material properties of nanomaterials can be altered substantially by interactions with tissue thus making it important to assess them in the specific biological context to understand and tailor their effects. Here, a genetically controlled system is optimized for cellular uptake of superparamagnetic ferritin and subsequent trafficking to lysosomes. High local concentrations of photoabsorbing magnetoferritin give robust contrast in optoacoustic imaging and allow for selective photoablation of cells overexpressing ferritin receptors. Genetically controlled uptake of the biomagnetic nanoparticles also strongly enhances third-harmonic generation due to the change of refractive index caused by the magnetiteprotein interface of ferritins entrapped in lysosomes. Selective uptake of magnetoferritin furthermore enables sensitive detection of receptor-expressing cells by magnetic resonance imaging, as well as efficient magnetic cell sorting and manipulation. Surprisingly, a substantial increase in the blocking temperature of lysosomally entrapped magnetoferritin is observed, which allows for specific ablation of genetically defined cell populations by local magnetic hyperthermia. The subcellular confinement of superparamagnetic ferritins thus enhances their physical properties to empower genetically controlled interrogation of cellular processes with deep tissue penetration.The interest in overexpressed ferritin has recently been revived in attempts to create biomagnetic actuators aimed at evoking controlled cellular responses to magnetic fields. In this regard, ferritin was used to manipulate cellular processes via magnetic hyperthermia or magnetomechanical transduction, [4] although the biophysical mechanisms underlying these effects are so far not understood well on a theoretical level. [5] Fully genetically encoded sensors and actuators, which do not necessitate supplementation of synthetic components, have become the frequently preferred solutions for, e.g., fluorescent Ca 2+ imaging and optogenetics. However, with regard to noninvasive techniques with deep tissue penetration such as optoacoustic (OA) imaging or MRI, synthetic nanostructures often still possess superior material properties as compared to genetically encodable biomaterials.Semigenetic approaches, which consist of a genetic component that interacts with an exogenous compound, can exploit the superior physical properties of synthetic nanostructures for remote cell actuation and deep tissue imaging and at the same time benefit from genetic targetability. [6] A recent study showcased the use of ferritin in a semigenetic approach to obtain cellular MR-contrast. [7] It was hypothesized that the enhanced contrast resulted from ferritin agglomeration inside lysosomes after cellular uptake through murine T cell immunoglobulin domain and mucin domain 2 (Tim-2) receptor. This contrastenhancing effect could be exploited even more effectively if the...

Size-selected Fe3O4–Au hybrid nanoparticles for improved magnetism-based theranostics

“…Fitting H C ( T ) yields an average blocking temperature T B which can be translated into K eff via 21· k B T ≈ K eff · V where k B the Boltzmann constant and V the NP volume. The prefactor 21 accounts for an attempt frequency of 10 9 Hz and the VSM measurement time of 1 s [ 51 ].…”

Magnetoferritin: Process, Prospects, and Their Biomedical Applications

“…A semigenetic system used a genetic component, which interacted with exogenous components, which realized deep tissue imaging with genetic targetability [94]. It was previously reported that MFt was internalized into cells and subsequent trafficked to lysosomes through semigenetic approaches [79]. By controlling the expression of ferritin receptors, cells could uptake biosynthetic MFt and native ferrihydrite-containing ferritin, which accumulated in lysosomes.…”

“…The cobalt doping along with loss of crystallinity resulted in enhanced magnetic anisotropy, which was in conflict with the reported formation of antiferromagnetic Co 3 O 4 [55]. The semigenetic system, which allowed genetic targetability, enabled magnetic cell manipulation and cell ablation by photoablation or local magnetic hyperthermia [79]. Therefore, combining tumor imaging and tumor therapy is promising for practical applications, and different methods of cancer treatment may benefit from the use of MFt.…”

Development and characterization of folic acid-functionalized apoferritin as a delivery vehicle for epirubicin against MCF-7 breast cancer cells

“…MTT assay showed that 2 mM of free Epr, Epr-loaded HsAFr and HsAFr-Epr-FA diminish the cell growth up to 44 ± 5.1, 35 ± 3.32 and 26.66 ± 2.61 (%) respectively after 24 h, while after 72 h reduce the cell growth up to 35.33 ± 4.86, 25.83 ± 1.42 and 15 ± 4.6 (%), respectively. Higher toxicity of HsAFr-Epr-FA suggested, firstly, that the nanocarriers have high affinity for tumour cells due to their ability to bind FRs due to the presence of FA, and secondly the HsAFr can enter tumour cells through the interactions with scavenger receptor (SCARA5) and TfR1 overexpressed in the membranes of tumour cells [54]. H subunits are able to bind transferrin receptors while L subunits bind SCARA5 receptors [55].…”